Clinical Trial

Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-31.
Trial Details
NCT Number NCT07110051
Lead Sponsor National Cancer Institute, Egypt
Conditions Tramadol, Nalbuphine, Abdominal Surgeries, Pediatric Cancer
Enrollment 128 participants
Start Date 2025-01-15
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-11